KeyCorp Other Income (Expense) increased by 157.1% to $18.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 157.1%, from $7.00M to $18.00M. Over 3 years (FY 2021 to FY 2025), Other Income (Expense) shows a downward trend with a -45.1% CAGR.
An increase suggests higher non-operating gains or lower non-operating costs, while a decrease indicates higher non-operating expenses or lower non-operating income.
Represents the net total of non-operating financial activities, including interest income, interest expense, foreign cur...
Standard across all public companies; peers in the medical device sector often show similar volatility due to currency fluctuations.
other_income_expense_net| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $13.00M | $20.00M | $55.00M | -$5.00M | $3.00M | $13.00M | $11.00M | $0.00 | $4.00M | $22.00M | $13.00M | $9.00M | $21.00M | -$2.00M | $7.00M | $1.00M | $8.00M | $7.00M | $18.00M |
| QoQ Change | — | +53.8% | +175.0% | -109.1% | +160.0% | +333.3% | -15.4% | -100.0% | — | +450.0% | -40.9% | -30.8% | +133.3% | -109.5% | +450.0% | -85.7% | +700.0% | -12.5% | +157.1% |
| YoY Change | — | — | — | — | -76.9% | -35.0% | -80.0% | +100.0% | +33.3% | +69.2% | +18.2% | — | +425.0% | -109.1% | -22.2% | -95.2% | +500.0% | — | +157.1% |